ArticleCommunications chemistry2026
Disentangling coevolutionary constraints for modeling protein conformational heterogeneity.
Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate characterization of multi-state protein conformations is crucial for understanding their functional mechanisms and advancing targeted therapies. Extracting coevolutionary constraints from homologous sequences helps reveal protein structure and function, which can be automatically captured by MSA Transformer leveraging attention mechanisms. Making use of the multi-conformational coevolutionary signals captured by MSA Transformer, we introduce in this study EvoSplit to disentangle coevolutionary signals associated with distinct conformations to guide protein structure predictions. EvoSplit outperforms AF-Cluster on 85 fold-switching proteins and successfully models the conformations of proteins beyond AlphaFold2's training set. We then identify 54 candidates with potential conformational diversity for cancer-related human proteins. Notably, for five GTPases, EvoSplit consistently predicts two conformations, one of which has not been previously reported. As an important example, the protein-protein interaction analysis provides new insights into novel HRAS function-associated conformations. Furthermore, the validity of these newly identified conformations is examined by evolutionary analysis and extensive molecular dynamics simulations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.